"Monroe Biomedical Research is a dedicated outpatient clinical research center committed to the development of novel therapies for chronic diseases. We offer patients the opportunity to participate in cutting edge clinical studies. Our top priority is the health, safety, and comfort of our study volunteers."

During the past decade, Monroe Biomedical Research conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 7 clinical trials were completed, i.e. on average, 30.4% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 7 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Monroe Biomedical Research" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Verona Pharma plc" with 2 trials sponsored, "Adamis Pharmaceuticals Corporation" with 1 trials sponsored and "American Regent, Inc." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Monroe Biomedical Research" #1 collaborator was "AbCellera Biologics Inc." with 2 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 2 trials as a collaborator, "Celerion" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Monroe Biomedical Research" are "COVID-19" (6 trials), "Covid19" (3 trials), "Asthma" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Monroe Biomedical Research" in a lesser frequency.

Most popular intervention types in "Monroe Biomedical Research" are "Drug" (20 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials), "Ensifentrine" (2 trials) and "AS MDI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monroe Biomedical Research" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Monroe Biomedical Research". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Monroe Biomedical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Monroe Biomedical Research, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".